You are here

Article info

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Antiretroviral combination therapy markedly reduces risk of heterosexual HIV-1 transmission

Authors

  1. Correspondence to Eric S Rosenberg
    Department of Medicine and Pathology, Massachusetts General Hospital, Gray J-504, 55 Fruit Street, Boston, MA 02114, USA; erosenberg1{at}partners.org
View Full Text

Citation

Lichterfeld M, Rosenberg ES
Antiretroviral combination therapy markedly reduces risk of heterosexual HIV-1 transmission
BMJ Evidence-Based Medicine 2012;17:95-96.

Publication history

  • First published November 22, 2011.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions